Aptilon Announces 2011 First Quarter Results

MONTREAL, June 29, 2011 /CNW/ -- 
MONTREAL, June 29, 2011 /CNW/ - Aptilon Corporation ("Aptilon" or the
 "Company") (TSXV: APZ), a leader in online access to, engagement and
 interaction with physicians and healthcare professionals on behalf of
 pharmaceutical and life sciences companies, today announced its
 financial results for the three-month period ended March 31, 2011.
 Financial references are in CDN dollars. Complete financial statements
 and MD&A are available on SEDAR at www.sedar.com.


Highlights:


    --  First quarterly report completed following successful
        conversion to International Financial Reporting Standards
        ("IFRS").

    --  Initiated delivery updates of its product line and 'cloud'
        based services designed to increase opportunities to access,
        engage and interact with healthcare professionals via any
        channel and any device. These updates are expected to continue
        in the second quarter and positively impact the Company's
        results in the second half of 2011.

    --  Revenue for the three-month period ended March 31, 2011 reached
        $7.2 million, a decrease of 6% from $7.66 million during the
        same period a year earlier. Most of the change was attributed
        to the strengthening value of the Canadian dollar compared to
        the US dollar.

    --  Gross margin was maintained at approximately 54% in the
        quarter, reaching $3.9 million from $4.2 million in the same
        quarter a year earlier.

    --  Operating expenses in the period decreased 9% to $3.36 million
        from $3.68 million in the first quarter of 2010.

    --  Quarterly comprehensive net income improved 6% to a loss of
        $0.64 million from a loss of $0.68 million during the same
        period a year earlier.

    --  Generated positive net cash flow from operations of $1.54
        million reversing the cash used by operations of $0.55 million
        in the prior year.



Subsequent to the end of the period, the Company successfully extended
 the repayment period of the secured promissory note in the amount of
 US$27,200,000 issued in September 2009 in connection with the purchase
 of substantially all the assets of Direct Medical Data, LLC and BLM
 Incorporated related to their healthcare marketing services. The
 original note provided for monthly installments, and a lump sum payment
 of approximately US$12,417,000 on September 15, 2012. The original note
 and associated lump sum payments were replaced by a new secured
 promissory note in the amount of US$21,750,000, being the balance due
 under the original note as of April 14, 2011. The new note bears
 interest at the rate of 6.9% per annum and is repayable in increasing
 monthly installments (ranging from US$226,000 for the first 9 months to
 US$600,000 for 11 of the last 12 months) from April 15, 2011 until
 December 15, 2015. It is secured and guaranteed in the same manner as
 the original note.


About Aptilon Corporation


Aptilon enables pharmaceutical, biotech and medical device companies to
 effectively reach, message, connect and interact with US physicians and
 healthcare professionals on the Internet and over mobile devices via
 multiple access channels. Its innovative service offerings provide
 targeted impressions and interactions through: video and mobile
 detailing, ReachNet(SM) Physician Access Channel, the DMD database and permission-based email
 services. Top US pharmaceutical companies and respected healthcare
 organizations have adopted Aptilon's solutions to market to, engage and
 interact with leading healthcare practitioners. For more information,
 visit www.aptilon.com.


ReachNet(SM) is a service mark of Aptilon Corporation.


Forward-looking statements


This news release may contain forward-looking statements. These
 statements relate to future events or future performance and reflect
 management's current expectations and assumptions. Such forward-looking
 statements reflect management's current beliefs and are based on
 information currently available to management of Aptilon. A number of
 factors could cause actual events, performance or results to differ
 materially from the events performance and results discussed in the
 forward-looking statements. These forward-looking statements are made
 as of the date hereof and Aptilon does not assume any obligation to
 update or revise them to reflect new events or circumstances.


Neither TSX Venture Exchange nor its Regulation Services Provider (as
 that term is defined in the policies of the TSX Venture Exchange)
 accepts responsibility for the adequacy or accuracy of this release.


To view this news release in HTML formatting, please use the following URL: http://www.newswire.ca/en/releases/archive/June2011/29/c2483.html



p Mr. Denis Martineaubr/ Presidentbr/ Aptilon Corporationbr/ 1-888-544-8866br/ a href="mailto:[e-mail]"[e-mail]/a /p 

Copyright